Review best practices for opioid prescribing and get expert insight into using newer non-opioid analgesics -- including cannabis and cannabis-related products -- to expand pain management options available to your patients suffering from acute and chronic pain during the AAPM 2020 Pharmacologic Management of Pain preconference course. The full day course will take place Wednesday, February 26, at the Gaylord National Convention Center in National Harbor, MD.
This was so useful.
This course has guided positive changes in my practice.
-2019 course participants
Hear the latest guidance on implementing evidence-based, patient-centered approaches to opioid prescribing, opioid tapering, and managing opioid use disorder from leading experts in the field.
Amidst the ongoing opioid overdose crisis and rapidly evolving opioid prescribing guidelines, opinions, and laws, it is a challenging time to practice pain medicine. Along with course directors Michael Hooten, MD, and Steven Stanos, DO, presenting faculty members Jeffrey Gudin, MD; Helena Gazelka, MD; and Charles Argoff, MD, will deliver talks about opioid pharmacology, monitoring patients on chronic opioid therapy, and best practices for opioid tapering. Attendees will walk away with practical tips and information that allows them to optimize appropriate opioid analgesic use while applying a patient-centered approach to mitigate the risks of abuse, misuse, addiction, and diversion.
Optimize a rational polypharmacy approach to managing chronic pain.
The course is designed to help you better integrate various medications from different pharmacologic classes in order to optimize a rational polypharmacy approach to managing chronic pain. Presenters take into account the added challenge of comorbid symptoms, such as depression, anxiety, and sleep disturbances.
The Rapid Fire Pharmacotherapy Review will offer a rundown on
- NSAIDs and muscle relaxants (presented by Zachary McCormick, MD)
- Buprenorphine (Charles Argoff, MD)
- Ketamine (Michael Hooten, MD)
- Anticoagulant management in pain medicine (Zachary McCormick, MD)
- Pharmacologic management of migraine (James Watson, MD)
Cannabinoid pharmacology, regulation, dosing, dispensaries, quality control, and integrating medical cannabis into clinical practice.
The growing and evolving controversy of the therapeutic application of cannabis and cannabis-related products is an additional question facing providers today. The AAPM 2020 Pharmacologic Management of Pain preconference course will cover cannabinoids from bench to bedside to dispensary. Mark Wallace, MD, will discuss pharmacology. David Edwards, MD PhD, will give an update on the regulatory environment of medical cannabis. Grace Forde, MD, will offer guidance on integrating cannabis into clinical practice. Michelle Sexton, ND, will cover cannabis dosing, dispensaries, and quality control.